Trials / Sponsors / Joachim Aerts, MD PhD
Joachim Aerts, MD PhD
Academic / Other · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With M Metastatic Pancreatic Cancer | Phase 1 / Phase 2 | 2024-01-09 |
| Completed | MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial) Metastatic Pancreatic Cancer | Phase 1 | 2021-08-30 |
| Completed | The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC Non-small Cell Lung Cancer | N/A | 2021-07-06 |